Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effect of Perilla Extract on Improvement on Gastrointestinal Discomfort

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Nuoroda įrašoma į mainų sritį
StatusasBaigta
Rėmėjai
Amino Up Chemicals Co., Ltd.

Raktažodžiai

Santrauka

In the current study the effects of proprietary Perilla frutescens leaf extract in comparison to Maltodextrin, a fully digestible carbohydrate (placebo control), on gastrointestinal discomfort and bowel function were investigated. The study was performed double-blind and placebo-controlled with a 4 week intervention period. Study products were taken two times daily (each one capsule before breakfast and dinner).

Datos

Paskutinį kartą patikrinta: 07/31/2013
Pirmasis pateikimas: 08/22/2013
Numatytas registravimas pateiktas: 08/28/2013
Pirmas paskelbtas: 08/29/2013
Paskutinis atnaujinimas pateiktas: 08/28/2013
Paskutinis atnaujinimas paskelbtas: 08/29/2013
Faktinė studijų pradžios data: 06/30/2012
Numatoma pirminio užbaigimo data: 10/31/2012
Numatoma studijų užbaigimo data: 10/31/2012

Būklė ar liga

Abdominal Pain/ Discomfort
Slightly Constipation

Intervencija / gydymas

Dietary Supplement: Perilla extract

Dietary Supplement: Maltodextrin

Fazė

-

Rankų grupės

RankaIntervencija / gydymas
Experimental: Perilla extract
Experimental arm: Perilla extract
Dietary Supplement: Perilla extract
Placebo Comparator: Maltodextrin
Placebo arm: Maltodextrin
Dietary Supplement: Maltodextrin

Tinkamumo kriterijai

Amžius, tinkami studijuoti 30 Years Į 30 Years
Tinkamos studijoms lytysAll
Priima sveikus savanoriusTaip
Kriterijai

Inclusion Criteria:

- Healthy volunteers without clinical diagnosed diseases with relevant effect on the gastrointestinal system or on visceral motility.

- BMI: 19-30 kg/m2

- Reduced bowel movements defined as an average of >1 and ≤ 3.5 stools per week for at least the previous 6 months

- Gastrointestinal symptoms of at least 5 points

- Male or female

- Age ≥ 30 and ≤ 70 years

- Nonsmoker

- Written consent to participate in the study

- Able and willing to follow the study protocol procedures

Exclusion Criteria:

- Subject under prescription for medication for digestive symptoms such as anti-spasmodic, laxatives and anti-diarrheic drugs or other digestive auxiliaries

- Relevant history, presence of any medical disorder or intake of medication / dietary supplements, potentially interfering with this trial at screening

- Subjects with stool frequency of ≤ 1 stool every 7 days or > 3,5 stools per week

- Subjects not willing to avoid pre- and probiotics for the duration of the study

- Intake of antibiotics in the last 4 weeks and laxatives in the last 2 weeks

- Change of dietary habits within the 4 weeks prior to screening (for instance start of a diet high in fibers)

- Pregnant subject or subject planning to become pregnant during the study; breast-feeding subject.

- Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to co-operate during the study.

- Participants anticipating a change in their lifestyle or physical activity levels since this may also influence the results.

- Known food intolerance or allergy.

- Subject involved in any clinical or food study within the preceding month

Rezultatas

Pirminės rezultatų priemonės

1. daily gastrointestinal symptoms [was assessed daily during 4 week intervention]

The following gastrointestinal were rated and reported by the study participants on a daily based. Bloating, rumbling, feeling of fullness, passage of gas, abdominal discomfort (pain and cramps). The rating was done based on a number scale. 0 not at all and 4 extremely.

Antrinės rezultatų priemonės

1. validated questionnaires [assessed at visit 1 (before) and at visit 2 (after 4 week intervention)]

Three validated questionnaires were used. Two of them were specially designed to evaluate gastrointestinal symptoms and quality of life of people with constipation. The third questionnaire was a validated questionnaire to report stress levels and related changes of stress levels. Patient assessment of constipation symptoms (PAC SYM) Patents assessment of constipation quality of life (PAC QOL) Perceived stress questionnaire (PSQ20)

2. stool consistency [reported at days with stool during 4 week intervention]

The stool consistency was rated referring to the Bristol stool scale. A scale indicated with pictures how the stool consistency can be rated.

3. Adverse events [assessed at visit 1 (before) and at visit 2 (after 4 week intervention)]

All adverse events which might be linked to the study product were reported. As the tested study product is a food product being safe for consumption as food no specific parameter to define safety were defined.

4. Stool frequency [reported at days with stool during 4 week intervention]

The stool frequency was reported on each day with bowel movement.

Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge